Prev：Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response.(KTE6011-10.6)
Next：Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy(BMD0072-26.6)
